Influence of Natural Polysaccharides on Intestinal Microbiota in Inflammatory Bowel Diseases: An Overview
The incidence of inflammatory bowel disease (IBD) has increased in recent years. Considering the potential side effects of conventional drugs, safe and efficient treatment methods for IBD are required urgently. Natural polysaccharides (NPs) have attracted considerable attention as potential therapeu...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Foods |
Subjects: | |
Online Access: | https://www.mdpi.com/2304-8158/11/8/1084 |
_version_ | 1797434734971715584 |
---|---|
author | Qi Li Linyan Li Qiqiong Li Junqiao Wang Shaoping Nie Mingyong Xie |
author_facet | Qi Li Linyan Li Qiqiong Li Junqiao Wang Shaoping Nie Mingyong Xie |
author_sort | Qi Li |
collection | DOAJ |
description | The incidence of inflammatory bowel disease (IBD) has increased in recent years. Considering the potential side effects of conventional drugs, safe and efficient treatment methods for IBD are required urgently. Natural polysaccharides (NPs) have attracted considerable attention as potential therapeutic agents for IBD owing to their high efficiency, low toxicity, and wide range of biological activities. Intestinal microbiota and their fermentative products, mainly short-chain fatty acids (SCFAs), are thought to mediate the effect of NPs in IBDs. This review explores the beneficial effects of NPs on IBD, with a special focus on the role of intestinal microbes. Intestinal microbiota exert alleviation effects via various mechanisms, such as increasing the intestinal immunity, anti-inflammatory activities, and intestinal barrier protection via microbiota-dependent and microbiota-independent strategies. The aim of this paper was to document evidence of NP–intestinal microbiota-associated IBD prevention, which would be helpful for guidance in the treatment and management of IBD. |
first_indexed | 2024-03-09T10:36:43Z |
format | Article |
id | doaj.art-d9343fd57112446ebbd69844e6c30c08 |
institution | Directory Open Access Journal |
issn | 2304-8158 |
language | English |
last_indexed | 2024-03-09T10:36:43Z |
publishDate | 2022-04-01 |
publisher | MDPI AG |
record_format | Article |
series | Foods |
spelling | doaj.art-d9343fd57112446ebbd69844e6c30c082023-12-01T20:53:30ZengMDPI AGFoods2304-81582022-04-01118108410.3390/foods11081084Influence of Natural Polysaccharides on Intestinal Microbiota in Inflammatory Bowel Diseases: An OverviewQi Li0Linyan Li1Qiqiong Li2Junqiao Wang3Shaoping Nie4Mingyong Xie5State Key Laboratory of Food Science and Technology, China-Canada Joint Lab of Food Science and Technology (Nanchang), Key Laboratory of Bioactive Polysaccharides of Jiangxi Province, Nanchang University, Nanchang 330047, ChinaState Key Laboratory of Food Science and Technology, China-Canada Joint Lab of Food Science and Technology (Nanchang), Key Laboratory of Bioactive Polysaccharides of Jiangxi Province, Nanchang University, Nanchang 330047, ChinaCenter for Microbial Ecology and Technology (CMET), Faculty of Bioscience Engineering, Ghent University, 9000 Ghent, BelgiumState Key Laboratory of Food Science and Technology, China-Canada Joint Lab of Food Science and Technology (Nanchang), Key Laboratory of Bioactive Polysaccharides of Jiangxi Province, Nanchang University, Nanchang 330047, ChinaState Key Laboratory of Food Science and Technology, China-Canada Joint Lab of Food Science and Technology (Nanchang), Key Laboratory of Bioactive Polysaccharides of Jiangxi Province, Nanchang University, Nanchang 330047, ChinaState Key Laboratory of Food Science and Technology, China-Canada Joint Lab of Food Science and Technology (Nanchang), Key Laboratory of Bioactive Polysaccharides of Jiangxi Province, Nanchang University, Nanchang 330047, ChinaThe incidence of inflammatory bowel disease (IBD) has increased in recent years. Considering the potential side effects of conventional drugs, safe and efficient treatment methods for IBD are required urgently. Natural polysaccharides (NPs) have attracted considerable attention as potential therapeutic agents for IBD owing to their high efficiency, low toxicity, and wide range of biological activities. Intestinal microbiota and their fermentative products, mainly short-chain fatty acids (SCFAs), are thought to mediate the effect of NPs in IBDs. This review explores the beneficial effects of NPs on IBD, with a special focus on the role of intestinal microbes. Intestinal microbiota exert alleviation effects via various mechanisms, such as increasing the intestinal immunity, anti-inflammatory activities, and intestinal barrier protection via microbiota-dependent and microbiota-independent strategies. The aim of this paper was to document evidence of NP–intestinal microbiota-associated IBD prevention, which would be helpful for guidance in the treatment and management of IBD.https://www.mdpi.com/2304-8158/11/8/1084polysaccharidesinflammatory bowel diseaseintestinal microbiotaintestinal immunityshort-chain fatty acids |
spellingShingle | Qi Li Linyan Li Qiqiong Li Junqiao Wang Shaoping Nie Mingyong Xie Influence of Natural Polysaccharides on Intestinal Microbiota in Inflammatory Bowel Diseases: An Overview Foods polysaccharides inflammatory bowel disease intestinal microbiota intestinal immunity short-chain fatty acids |
title | Influence of Natural Polysaccharides on Intestinal Microbiota in Inflammatory Bowel Diseases: An Overview |
title_full | Influence of Natural Polysaccharides on Intestinal Microbiota in Inflammatory Bowel Diseases: An Overview |
title_fullStr | Influence of Natural Polysaccharides on Intestinal Microbiota in Inflammatory Bowel Diseases: An Overview |
title_full_unstemmed | Influence of Natural Polysaccharides on Intestinal Microbiota in Inflammatory Bowel Diseases: An Overview |
title_short | Influence of Natural Polysaccharides on Intestinal Microbiota in Inflammatory Bowel Diseases: An Overview |
title_sort | influence of natural polysaccharides on intestinal microbiota in inflammatory bowel diseases an overview |
topic | polysaccharides inflammatory bowel disease intestinal microbiota intestinal immunity short-chain fatty acids |
url | https://www.mdpi.com/2304-8158/11/8/1084 |
work_keys_str_mv | AT qili influenceofnaturalpolysaccharidesonintestinalmicrobiotaininflammatoryboweldiseasesanoverview AT linyanli influenceofnaturalpolysaccharidesonintestinalmicrobiotaininflammatoryboweldiseasesanoverview AT qiqiongli influenceofnaturalpolysaccharidesonintestinalmicrobiotaininflammatoryboweldiseasesanoverview AT junqiaowang influenceofnaturalpolysaccharidesonintestinalmicrobiotaininflammatoryboweldiseasesanoverview AT shaopingnie influenceofnaturalpolysaccharidesonintestinalmicrobiotaininflammatoryboweldiseasesanoverview AT mingyongxie influenceofnaturalpolysaccharidesonintestinalmicrobiotaininflammatoryboweldiseasesanoverview |